论文部分内容阅读
目的探析阿奇霉素与甲泼尼龙联合治疗小儿难治性支原体肺炎的疗效及安全性。方法回顾选取2015年11月至2016年12月本院医治的97例难治性支原体肺炎患儿资料加以探究,因医治药物不同可分成两组,其对照组(45例)予以阿奇霉素,而研究组(52例)予以甲泼尼龙联合阿奇霉素,并对两组疗效指标、药物副反应进行比对。结果研究组治愈、退热等所用的时间均较对照组短(P<0.05)。结论 RMPP患儿行甲泼尼龙联合阿奇霉素医治可缩短退热、咳嗽缓解的时间,提高临床疗效,并且无严重性药物副反应。
Objective To investigate the efficacy and safety of azithromycin combined with methylprednisolone in the treatment of refractory mycoplasma pneumonia in children. Methods The data of 97 children with refractory mycoplasma pneumonia treated in our hospital from November 2015 to December 2016 were retrospectively studied. Two groups were divided into two groups according to the different therapeutic drugs, and the control group (45 cases) was treated with azithromycin (52 cases) were given methylprednisolone combined with azithromycin, and the two groups of efficacy indicators, drug side effects were compared. Results The healing time and antipyretic time in the study group were shorter than those in the control group (P <0.05). Conclusion The treatment of methylprednisolone combined with azithromycin in children with RMPP can shorten the time to relieve fever and cough, improve the clinical curative effect and have no serious side effects of drugs.